Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    This change adds new revision history entries (2026-07-23, 2026-07-22) and a Revision: v3.6.4, and removes the previous revision entry (v3.6.3). The updates reflect site maintenance/versioning metadata for the page rather than changes to the study content.
    Difference
    0.2%
    Check dated 2026-07-27T05:56:21.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    New update dates were added for 2026-07-15 through 2026-07-17, and older update dates were removed (2026-02-20, 2026-07-07, 2026-07-08). This reflects maintenance of the page's update history rather than changes to the study data.
    Difference
    0.2%
    Check dated 2026-07-20T00:16:20.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The study record's update history shows new timestamps for 2026-07-08 and 2026-07-07, and older entries were removed; this reflects maintenance of the log rather than changes to the study details.
    Difference
    0.2%
    Check dated 2026-07-12T17:49:40.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.3) dated 2026-07-02 was added, and the prior revision (v3.6.2) from June 2026 was removed. This reflects routine maintenance of the study record’s version history rather than substantive changes to the study details.
    Difference
    0.2%
    Check dated 2026-07-05T14:27:18.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2, reflecting an internal update to the page. This change does not affect the study details, eligibility criteria, or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-28T08:32:50.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New navigation links were added to help users find who can join, contact information, how to read a study record, common questions, and how to join, and a version stamp 'Revision: v3.6.0' was introduced. The existing 'Intervention / Treatment' label was updated to 'Intervention/Treatment' to standardize terminology.
    Difference
    0.5%
    Check dated 2026-06-13T17:53:34.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.